Innate responses to pollen allergens

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 1, 2015, Pages 79-88

  Hosoki, Koa ^a   Boldogh, Istvan ^b   Sur, Sanjiv ^a  

^a Division of Allergy and Immunology   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Allergic inflammation; aqueous pollen extract; lipid; NADPH oxidase; reactive oxygen species

Indexed keywords

INTRINSIC FACTOR; LIPID; POLLEN ANTIGEN; POLLEN EXTRACT; PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TIGHT JUNCTION PROTEIN; TOLL LIKE RECEPTOR 9; OXIDOREDUCTASE; PLANT ANTIGEN;

ALLERGIC REACTION; AQUEOUS SOLUTION; CONJUGATE; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; REVIEW; TH2 CELL; ANIMAL; IMMUNOLOGY; METABOLISM; POLLEN; POLLEN ALLERGY;

ANIMALS; ANTIGENS, PLANT; HUMANS; IMMUNITY, INNATE; NADH, NADPH OXIDOREDUCTASES; NEUTROPHILS; POLLEN; REACTIVE OXYGEN SPECIES; RHINITIS, ALLERGIC, SEASONAL; TH2 CELLS;

EID: 84920829497     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000136     Document Type: Review

References (93)

1. Bowler RP, Crapo JD. Oxidative stress in allergic respiratory diseases. J Allergy Clin Immunol 2002; 110:349-356.
2. Gratziou C, Rovina N, Makris M, et al. Breath markers of oxidative stress and airway inflammation in seasonal allergic rhinitis. Int J Immunopathol Pharmacol 2008; 21:949-957.
3. Comhair SA, Bhathena PR, Dweik RA, et al. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 2000; 355:624.
4. Dworski R, Roberts LJ 2nd, Murray JJ, et al. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha). Clin Exp Allergy 2001; 31: 387-390.
5. Peterson JD, Herzenberg LA, Vasquez K, Waltenbaugh C. Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. Proc Natl Acad Sci USA 1998; 95:3071-3076.
6. Chan RC, Wang M, Li N, et al. Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell responses involved in T-helper differentiation. J Allergy Clin Immunol 2006; 118:455-465.
7. Csillag A, Boldogh I, Pazmandi K, et al. Pollen-induced oxidative stress influences both innate and adaptive immune responses via altering dendritic cell functions. J Immunol 2010; 184:2377-2385.
8. Matsue H, Edelbaum D, Shalhevet D, et al. Generation and function of reactive oxygen species in dendritic cells during antigen presentation. J Immunol 2003; 171:3010-3018.
9. Boldogh I, Bacsi A, Choudhury BK, et al. ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J Clin Invest 2005; 115:2169-2179.
10. Bacsi A, Dharajiya N, Choudhury BK, et al. Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J Allergy Clin Immunol 2005; 116:836-843.
11. Dharajiya N, Choudhury BK, Bacsi A, et al. Inhibiting pollen reduced nico-tinamide adenine dinucleotide phosphate oxidase-induced signal by intrapul-monary administration of antioxidants blocks allergic airway inflammation. J Allergy Clin Immunol 2007; 119:646-653.
12. Kruzel ML, Bacsi A, Choudhury B, et al. Lactoferrin decreases pollen antigen-induced allergic airway inflammation inamurine model ofasthma. Immunology 2006; 119:159-166.
13. Chodaczek G, Saavedra-Molina A, Bacsi A, et al. Iron-mediated dismutation of superoxide anion augments antigen-induced allergic inflammation: effect of lactoferrin. Postepy Hig Med Dosw (Online) 2007; 61:268-276.
14. Calhoun WJ, Reed HE, Moest DR, Stevens CA. Enhanced superoxide production by alveolar macrophages and air-space cells, airway inflammation, and alveolar macrophage density changes after segmental antigen bronch-oprovocation in allergic subjects. Am Rev Respir Dis 1992; 145:317-325.
15. Sanders SP, Zweier JL, Harrison SJ, et al. Spontaneous oxygen radical production at sites of antigen challenge in allergic subjects. Am J Respir Crit Care Med 1995; 151:1725-1733.
16. Lommatzsch M, Julius P, Kuepper M, et al. The course of allergen-induced leukocyte infiltration in human and experimental asthma. J Allergy Clin Immunol 2006; 118:91-97.
17. Sevin CM, Newcomb DC, Toki S, et al. Deficiency of gp91phox inhibits allergic airway inflammation. Am J Respir Cell Mol Biol 2013; 49:396-402.
18. Aguilera-Aguirre L, Bacsi A, Saavedra-Molina A, et al. Mitochondrial dysfunction increases allergic airway inflammation. J Immunol 2009; 183:5379-5387.
19. Chodaczek G, Bacsi A, Dharajiya N, et al. Ragweed pollen-mediated IgE-independent release of biogenic amines from mast cells via induction of mitochondrial dysfunction. Mol Immunol 2009; 46:2505-2514.
20. Matsui T, Suzuki Y, Yamashita K, et al. Diphenyleneiodonium prevents reactive oxygen species generation, tyrosine phosphorylation, and histamine release in RBL-2H3 mast cells. Biochem Biophys Res Commun 2000; 276:742-748.
21. Mabalirajan U, Dinda AK, Kumar S, et al. Mitochondrial structural changes and dysfunction are associated with experimental allergic asthma. J Immunol 2008; 181:3540-3548.
22. Konradova V, Copova C, Sukova B, Houstek J. Ultrastructure of the bronchial epithelium in three children with asthma. Pediatr Pulmonol 1985; 1:182-187.
23. Hayashi T, Ishii A, Nakai S, Hasegawa K. Ultrastructure of goblet-cell metaplasia from Clara cell in the allergic asthmatic airway inflammation in a mouse model of asthma in vivo. Virchows Arch 2004; 444:66-73.
24. Shalaby KH, Allard-Coutu A, O'Sullivan MJ, et al. Inhaled birch pollen extract induces airway hyperresponsiveness via oxidative stress but independently of pollen-intrinsic NADPH oxidase activity, or the TLR4-TRIF pathway. J Immunol 2013; 191:922-933.
25. Heijink IH, Nawijn MC, Hackett TL. Airway epithelial barrier function regulates the pathogenesis of allergic asthma. Clin Exp Allergy 2014; 44:620-630.
26. Barbato A, Turato G, Baraldo S, et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006; 174:975-981.
27. Xiao C, Puddicombe SM, Field S, et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol 2011; 128:549-556; e541-e512.
28. Wan H, Winton HL, Soeller C, et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999; 104:123-133.
29. Vinhas R, Cortes L, Cardoso I, et al. Pollen proteases compromise the airway epithelial barrier through degradation of transmembrane adhesion proteins and lung bioactive peptides. Allergy 2011; 66:1088-1098.
30. Runswick S, Mitchell T, Davies P, et al. Pollen proteolytic enzymes degrade tight junctions. Respirology 2007; 12:834-842.
31. Blume C, Swindle EJ, Dennison P, et al. Barrier responses of human bronchial epithelial cells to grass pollen exposure. Eur Respir J 2013; 42:87-97.
32. Mariani V, Gilles S, Jakob T, et al. Immunomodulatory mediators from pollen enhance the migratory capacity of dendritic cells and license them for Th2 attraction. J Immunol 2007; 178:7623-7631.
33. Gilles S, Jacoby D, Blume C, et al. Pollen-derived low-molecular weight factors inhibit 6-sulfo LacNAc+ dendritic cells' capacity to induce T-helper type 1 responses. Clin Exp Allergy 2010; 40:269-278.
34. Gutermuth J, Bewersdorff M, Traidl-Hoffmann C, et al. Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo. J Allergy Clin Immunol 2007; 120:293-299.
35. Bashir ME, Lui JH, Palnivelu R, et al. Pollen lipidomics: lipid profiling exposes a notable diversity in 22 allergenic pollen and potential biomarkers of the allergic immune response. PLoS One 2013; 8:e57566.
36. Traidl-Hoffmann C, Mariani V, Hochrein H, et al. Pollen-associated phyto-prostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005; 201:627-636.
37. Gilles S, Mariani V, Bryce M, et al. Pollen-derived E1-phytoprostanes signal via PPAR-gamma and NF-kappaB-dependent mechanisms. J Immunol 2009; 182:6653-6658.
38. Abos-Gracia B, del Moral MG, Lopez-Relano J, et al. Olea europaea pollen lipids activate invariant natural killer T cells by upregulating CD1d expression on dendritic cells. J Allergy Clin Immunol 2013; 131:1393-1399; e1395.
39. Agea E, Russano A, Bistoni O, et al. Human CD1-restricted T cell recognition of lipids from pollens. J Exp Med 2005; 202:295-308.
40. Russano AM, Agea E, Corazzi L, et al. Recognition of pollen-derived phos-phatidyl-ethanolamine by human CD1d-restricted gamma delta T cells. J Allergy Clin Immunol 2006; 117:1178-1184.
41. Plotz SG, Traidl-Hoffmann C, Feussner I, et al. Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators. J Allergy Clin Immunol 2004; 113:1152-1160.
42. Traidl-Hoffmann C, Kasche A, Jakob T, et al. Lipid mediators from pollen act as chemoattractants and activators of polymorphonuclear granulocytes. J Allergy Clin Immunol 2002; 109:831-838.
43. Hoskins A, Reiss S, Wu P, et al. Asthmatic airway neutrophilia after allergen challenge is associated with the glutathione S-transferase M1 genotype. Am J Respir Crit Care Med 2013; 187:34-41.
44. Metzger WJ, Richerson HB, Worden K, et al. Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. Chest 1986; 89:477-483.
45. Roschmann KI, van Kuijen AM, Luiten S, et al. Purified Timothy grass pollen major allergen Phl p 1 may contribute to the modulation of allergic responses through a pleiotropic induction of cytokines and chemokines from airway epithelial cells. Clin Exp Immunol 2012; 167:413-421.
46. Roschmann K, Farhat K, Konig P, et al. Timothy grass pollen major allergen Phl p 1 activates respiratory epithelial cells by a nonprotease mechanism. Clin Exp Allergy 2009; 39:1358-1369.
47. Roschmann KI, Luiten S, Jonker MJ, et al. Timothy grass pollen extract-induced gene expression and signalling pathways in airway epithelial cells. Clin Exp Allergy 2011; 41:830-841.
48. Taverna S, Flugy A, Colomba P, et al. Effects of Parietaria judaica pollen extract on human microvascular endothelial cells. Biochem Biophys Res Commun 2008; 372:644-649.
49. Hosoki K, Aguilera-Aguirre L, Boldogh I, et al. Ragweed pollen extract (RWPE)-induces TLR4-dependent neutrophil recruitment that augments allergic airway. J Allergy Clin Immunol 2014; 133:AB59.
50. Park SJ, Wiekowski MT, Lira SA, Mehrad B. Neutrophils regulate airway responses in a model of fungal allergic airways disease. J Immunol 2006; 176:2538-2545.
51. Suzuki T, Wang W, Lin JT, et al. Aerosolized human neutrophil elastase induces airway constriction and hyperresponsiveness with protection by intravenous pretreatment with half-length secretory leukoprotease inhibitor. Am J Respir Crit Care Med 1996; 153:1405-1411.
52. Grosse-Steffen T, Giese T, Giese N, et al. Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase. Clin Dev Immunol 2012; 2012:720768.
53. Vega A, Ventura I, Chamorro C, et al. Neutrophil defensins: their possible role in allergic asthma. J Investig Allergol Clin Immunol 2011; 21:38-43.
54. Sakamoto N, Mukae H, Fujii T, et al. Differential effects of alpha-and beta-defensin on cytokine production by cultured human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005; 288:L508-L513.
55. Chu HW, Trudeau JB, Balzar S, Wenzel SE. Peripheral blood and airway tissue expression of transforming growth factor beta by neutrophils in asthmatic subjects and normal control subjects. J Allergy Clin Immunol 2000; 106:1115-1123.
56. Hampton MB, Kettle AJ, Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998; 92:3007-3017.
57. Li DQ, Zhang L, Pflugfelder SC, et al. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lympho-poietin/OX40 ligand/OX40 signaling pathways. J Allergy Clin Immunol 2011; 128:1318-1325; e1312.
58. Semlali A, Jacques E, Koussih L, et al. Thymic stromal lymphopoietin-induced human asthmatic airway epithelial cell proliferation through an IL-13-depen-dent pathway. J Allergy Clin Immunol 2010; 125:844-850.
59. Zhou B, Comeau MR, De Smedt T, et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat Immunol 2005; 6:1047-1053.
60. Gabriele L, Schiavoni G, Mattei F, et al. Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen. J Allergy Clin Immunol 2013; 132:686-695; e687.
61. Kamekura R, Kojima T, Takano K, et al. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis. Clin Exp Allergy 2012; 42:218-228.
62. Schmitz J, Owyang A, Oldham E, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005; 23:479-490.
63. Kurowska-Stolarska M, Stolarski B, Kewin P, et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol 2009; 183:6469-6477.
64. Barlow JL, Peel S, Fox J, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013; 132:933-941.
65. Rangasamy T, Williams MA, Bauer S, et al. Nuclear erythroid 2 p45-related factor 2 inhibits the maturation of murine dendritic cells by ragweed extract. Am J Respir Cell Mol Biol 2010; 43:276-285.
66. Kamijo S, Takai T, Kuhara T, et al. Cupressaceae pollen grains modulate dendritic cell response and exhibit IgE-inducing adjuvant activity in vivo. J Immunol 2009; 183:6087-6094.
67. Noirey N, Rougier N, Andre C, et al. Langerhans-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes. J Allergy Clin Immunol 2000; 105:1194-1201.
68. Werner M, Topp R, Wimmer K, et al. Heinrich J: TLR4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 2003; 112: 323-330.
69. Reijmerink NE, Bottema RW, Kerkhof M, et al. TLR-related pathway analysis: novel gene-gene interactions in the development of asthma and atopy. Allergy 2010; 65:199-207.
70. Fuertes E, Brauer M, MacIntyre E, et al. Childhood allergic rhinitis, traffic-related air pollution, and variability in the GSTP1, TNF, TLR2, and TLR4 genes: results from the TAG Study. J Allergy Clin Immunol 2013; 132:342-352; e342.
71. Kerkhof M, Postma DS, Brunekreef B, et al. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax 2010; 65:690-697.
72. Prefontaine D, Banville-Langelier AA, Fiset PO, et al. Children with atopic histories exhibit impaired lipopolysaccharide-induced Toll-like receptor-4 signalling in peripheral monocytes. Clin Exp Allergy 2010; 40:1648-1657.
73. Rodriguez D, Keller AC, Faquim-Mauro EL, et al. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003; 171:1001-1008.
74. Tan AM, Chen HC, Pochard P, et al. TLR4 signaling in stromal cells is critical for the initiation of allergic Th2 responses to inhaled antigen. J Immunol 2010; 184:3535-3544.
75. Eisenbarth SC, Piggott DA, Huleatt JW, et al. Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196:1645-1651.
76. Hammad H, Chieppa M, Perros F, et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15:410-416.
77. Trompette A, Divanovic S, Visintin A, et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457:585-588.
78. Shalaby KH, Jo T, Nakada E, et al. ICOS-expressing CD4 T cells induced via TLR4 in the nasal mucosa are capable of inhibiting experimental allergic asthma. J Immunol 2012; 189:2793-2804.
79. Mittag D, Varese N, Scholzen A, et al. TLR ligands of ryegrass pollen microbial contaminants enhance Th1 and Th2 responses and decrease induction of Foxp3(hi) regulatory T cells. Eur J Immunol 2013; 43:723-733.
80. Bonura A, Corinti S, Schiavi E, et al. The major allergen of the Parietaria pollen contains an LPS-binding region with immuno-modulatory activity. Allergy 2013; 68:297-303.
81. Hsu SC, Chen CH, Tsai SH, et al. Functional interaction of common allergens and a C-type lectin receptor, dendritic cell-specific ICAM3-grabbing nonintegrin (DC-SIGN), on human dendritic cells. J Biol Chem 2010; 285:7903-7910.
82. Currie AJ, Stewart GA, McWilliam AS. Alveolar macrophages bind and phagocytose allergen-containing pollen starch granules via C-type lectin and integrin receptors: implications for airway inflammatory disease. J Immunol 2000; 164:3878-3886.
83. Creticos PS, Schroeder JT, Hamilton RG, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006; 355:1445-1455.
84. Simons FE, Shikishima Y, Van Nest G, et al. Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimu-latory DNA. J Allergy Clin Immunol 2004; 113:1144-1151.
85. Tulic MK, Fiset PO, Christodoulopoulos P, et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004; 113:235-241.
86. Spertini F, Reymond C, Leimgruber A. Allergen-specific immunotherapy of allergy and asthma: current and future trends. Expert Rev Respir Med 2009; 3:37-51.
87. Rosewich M, Lee D, Zielen S. Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis. Hum Vaccin Immunother 2013; 9:1523-1531.
88. Murakami D, Kubo K, Sawatsubashi M, et al. Phase I/II study of oral im-munotherapy with Cry j1-galactomannan conjugate for Japanese cedar pollinosis. Auris Nasus Larynx 2014; 41:350-358.
89. Jahn-Schmid B, Siemann U, Zenker A, et al. Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12. Int Immunol 1997; 9:1867-1874.
90. Wallner M, Stocklinger A, Thalhamer T, et al. Allergy multivaccines created by DNA shuffling of tree pollen allergens. J Allergy Clin Immunol 2007; 120:374-380.
91. Herranz F, Schmidt-Weber CB, Shamji MH, et al. Superparamagnetic iron oxide nanoparticles conjugated to a grass pollen allergen and an optical probe. Contrast Media Mol Imaging 2012; 7:435-439.
92. Ogihara K, Savory N, Abe K, et al. DNA aptamers against the Cry j 2 allergen of Japanese cedar pollen for biosensing applications. Biosens Bioelectron 2015; 63:159-165.
93. Nair P, Gaga M, Zervas E, et al. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial. Clin Exp Allergy 2012; 42:1097-1103.